A competing risks analysis in BRCA1 mutation carriers that accounted for simultaneous associations with breast and ovarian cancer risks found similar HR estimates for breast cancer and no evidence of association with ovarian cancer risk (Supplementary Table 13). This evidence concerns the gene BRCA1 and breast cancer.